Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Roche Vision Of Rx Future Includes IT And China, But Not Large Sales Force

Executive Summary

Roche is keeping a close watch on information technology companies as potential emerging competitors for the pharmaceutical industry, CFO Erich Hunziker told the recent J.P. Morgan health care conference in San Francisco

You may also be interested in...



Roche/GSK Boniva Launch Plan Includes Reminders For Once-Monthly Dose

Roche and GlaxoSmithKline will support the launch of the osteoporosis therapy Boniva (ibandronate) with a program intended to help patients comply with the once-monthly oral dosing regimen

Roche/GSK Boniva Launch Plan Includes Reminders For Once-Monthly Dose

Roche and GlaxoSmithKline will support the launch of the osteoporosis therapy Boniva (ibandronate) with a program intended to help patients comply with the once-monthly oral dosing regimen

Global Rx Sales Reach $550 Bil., IMS Says; China Is Leading Growth

China is emerging as the most rapidly growing pharmaceutical market worldwide, IMS Health reported in its review of the global pharma market in 2004

Related Content

Topics

UsernamePublicRestriction

Register

PS045319

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel